105 related articles for article (PubMed ID: 23862978)
1. Recent structural advances of β1 and β2 adrenoceptors yield keys for ligand recognition and drug design.
Soriano-Ursúa MA; Trujillo-Ferrara JG; Correa-Basurto J; Vilar S
J Med Chem; 2013 Nov; 56(21):8207-23. PubMed ID: 23862978
[TBL] [Abstract][Full Text] [Related]
2. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
[TBL] [Abstract][Full Text] [Related]
3. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
4. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
6. Identification of binding sites of bopindolol and its two metabolites with beta1-adrenoceptors by molecular modeling: comparison with beta2 adrenoceptors.
Hattori K; Ishiguro M; Ohnuki T; Nakamura T; Muramatsu I; Nagatomo T
Pharmacology; 1999 Apr; 58(4):183-9. PubMed ID: 10077737
[TBL] [Abstract][Full Text] [Related]
7. Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor.
Woo AY; Song Y; Zhu W; Xiao RP
Br J Pharmacol; 2015 Dec; 172(23):5477-88. PubMed ID: 25537131
[TBL] [Abstract][Full Text] [Related]
8. Effect of linker length and composition on heterobivalent ligand-mediated receptor cross-talk between the A1 adenosine and β2 adrenergic receptors.
Barlow N; Baker SP; Scammells PJ
ChemMedChem; 2013 Dec; 8(12):2036-46. PubMed ID: 24106065
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
10. Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.
Sabio M; Jones K; Topiol S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5391-5. PubMed ID: 18829308
[TBL] [Abstract][Full Text] [Related]
11. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine.
Weitl N; Seifert R
J Pharmacol Exp Ther; 2008 Dec; 327(3):760-9. PubMed ID: 18772317
[TBL] [Abstract][Full Text] [Related]
12. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.
Galandrin S; Bouvier M
Mol Pharmacol; 2006 Nov; 70(5):1575-84. PubMed ID: 16901982
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists.
Kleinau G; Pratzka J; Nürnberg D; Grüters A; Führer-Sakel D; Krude H; Köhrle J; Schöneberg T; Biebermann H
PLoS One; 2011; 6(10):e27073. PubMed ID: 22073124
[TBL] [Abstract][Full Text] [Related]
14. Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor.
Isogai S; Deupi X; Opitz C; Heydenreich FM; Tsai CJ; Brueckner F; Schertler GF; Veprintsev DB; Grzesiek S
Nature; 2016 Feb; 530(7589):237-41. PubMed ID: 26840483
[TBL] [Abstract][Full Text] [Related]
15. The role of conformational ensembles of seven transmembrane receptors in functional selectivity.
Vaidehi N; Kenakin T
Curr Opin Pharmacol; 2010 Dec; 10(6):775-81. PubMed ID: 20933468
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity.
Selvam B; Wereszczynski J; Tikhonova IG
Chem Biol Drug Des; 2012 Aug; 80(2):215-26. PubMed ID: 22530954
[TBL] [Abstract][Full Text] [Related]
17. Insights into signaling from the beta2-adrenergic receptor structure.
Audet M; Bouvier M
Nat Chem Biol; 2008 Jul; 4(7):397-403. PubMed ID: 18560432
[TBL] [Abstract][Full Text] [Related]
18. Observation of "ionic lock" formation in molecular dynamics simulations of wild-type beta 1 and beta 2 adrenergic receptors.
Vanni S; Neri M; Tavernelli I; Rothlisberger U
Biochemistry; 2009 Jun; 48(22):4789-97. PubMed ID: 19378975
[TBL] [Abstract][Full Text] [Related]
19. Characterisation and expression of β1-, β2- and β3-adrenergic receptors in the fathead minnow (Pimephales promelas).
Giltrow E; Eccles PD; Hutchinson TH; Sumpter JP; Rand-Weaver M
Gen Comp Endocrinol; 2011 Sep; 173(3):483-90. PubMed ID: 21827763
[TBL] [Abstract][Full Text] [Related]
20. beta1- and beta2-adrenoceptor induced synaptic facilitation in rat basolateral amygdala.
Abraham PA; Xing G; Zhang L; Yu EZ; Post R; Gamble EH; Li H
Brain Res; 2008 May; 1209():65-73. PubMed ID: 18396264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
